SLC2A1 and pulmonary fibrosis: Dihydromyricetin can alleviate lung fibrosis in mouse models through STAT3/pSTAT3/GLUT1 signaling pathway and inhibit fibroblast or myofibroblast differentiation, proliferation, and migration (Li et al., 2022).